Tantalizing Therapeutics in Bronchopulmonary Dysplasia

Tantalizing Therapeutics in Bronchopulmonary Dysplasia is a concise reference that provides an overview of emerging concepts in the understanding of lung development and injury from a molecular and cellular point-of-view, including exciting pathways that are paving the way for new options to prevent or treat Bronchopulmonary Dysplasia (BPD). The book's chapters are written by experts who are at the forefront of BPD research. Coverage includes chapters on exosomes, stem cells and miRs, as well as a section on new discoveries in BPD research with translational potential. This is a must-have reference for researchers, physicians and trainees working on BPD, lung developmental biology, and more.

• Includes discussions on which aspects of the bench research in Bronchopulmonary Dysplasia are the most promising areas
• Offers insights into the latest research being conducted that could potentially move to the bassinet (in the NICU)
• Contains evidence-based summaries and informed opinions about existing therapies

Researchers and physicians interested in diseases of the developing lung, including trainees (scientists doing their MS degrees, PhD-candidates pediatric residents and neonatal fellows)

Section 1: Current Therapeutics: State of the Art

1. Systemic and topical glucocorticoids to prevent BPD

2. Use of caffeine for prevention of BPD

Abhay Lodha, Stefani Doucette, and Vineet Bhandari

3. Next Generation ventilator strategies to prevent/manage BPD

Martin Keszler and Ashish Gupta

Section 2: Ongoing Therapeutic Studies with Translational Potential

4. End points for therapeutic trials for BPD: lessons learned from clinical trials

5. What can exogenous surfactant provide in the fight against BPD?

6. Stem cells in the treatment of BPD

So Yoon Ahn, Yun Sil Chang, Won Soon Park

Section 3: Future Therapeutic Directions

7. Extracellular vesicles in the therapy of BPD

8. Growth factors in the therapy of BPD

Heber C. Nielsen, Anne Chetty, and Vineet Bhandari

9. Antenatal approaches in the therapy of BPD

Andre Gie, Ignacio Valenzuela, Thomas Salaets, Jan Deprest, and Jaan Toelen

10. miRs –mere hype or master regulators in the therapy of BPD?

Charitharth Vivek Lal, Vivek Shukla, Namasivayam Ambalavanan, and Vineet Bhandari

11. Immune modulators for the therapy of BPD

Margaret Gilfillan and Vineet Bhandari